Polypharmacy and Drug-Drug Interactions Among Older Adults

This study uses a nationally representative sample to estimate changes in the use and concurrent use of prescription and over-the-counter (OTC) medications and dietary supplements among older adults in the US between 2015-2016 and 2021-2023, including use of potentially major drug-drug interactions.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-09-24
DOI
https://doi.org/10.1001/jama.2026.17268
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Polypharmacy and Drug-Drug Interactions Among Older Adults

Rupshikha Sen, Shyam Krishnan Ondanat Veetil, Qingrong Li, G. Caleb Alexander et al.
JAMA
Pharmaceutical Practices and Patient Outcomes
article

Polypharmacy and Drug-Drug Interactions Among Older Adults

Rupshikha Sen, Shyam Krishnan Ondanat Veetil, Qingrong Li, G. Caleb Alexander, Dima Mazen Qato, Jocelyn Wilder
article en

Abstract

This study uses a nationally representative sample to estimate changes in the use and concurrent use of prescription and over-the-counter (OTC) medications and dietary supplements among older adults in the US between 2015-2016 and 2021-2023, including use of potentially major drug-drug interactions.

JAMA
University of Southern California (US), Johns Hopkins University (US), National Opinion Research Center (US)
Openalex Percentile: Top 15%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.